2025-02-24
Healthcare focus drives HighLight Capital's exits amid market downturn
The Shanghai-based private investment firm achieved significant exits via trade sales
2025-02-06
ITM Announces Positive Topline Results of Phase 3 COMPETE Trial with ITM-11
Demonstrating clinically relevant and statistically significant benefit in Progression-Free Survival (PFS) compared to everolimus
2024-12-23
Ikena Oncology and Inmagene Announce Merger and Fundraising
Ikena Oncology and Inmagene Biopharmaceuticals announced they have entered into a definitive merger agreement
2024-12-04
Rgenta Therapeutics Announces Strategic Alliance with GSK
Rgenta Therapeutics announced that it has entered into a multi-year, multi-target strategic research alliance with pharma giant GSK
2024-11-15
GenScript to Receive Significant Revenue through its Involvement in $3.3 Billion Deal with Merck
GenScript Biotech announced that its CDMO subsidiary, ProBio, has licensed its PD-1 new molecular entity (NME) to LaNova Medicines
2024-12-31